The state of Nebraska currently has 2 active clinical trials seeking participants for Primary Biliary Cholangitis research studies. These trials are conducted in various cities, including Omaha, Lincoln, Kearney and Grand Island.
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Recruiting
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/10/2024
Locations: CHI Health Clinic (Alegent Creighton Clinic)- Gastroenterology-Bergan, Omaha, Nebraska
Conditions: Primary Biliary Cholangitis, PBC
Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
Recruiting
Saroglitazar Magnesium 1 mg and 2 mg tablets for treatment of subjects with Primary Biliary Cholangitis (PBC)
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
12/30/2023
Locations: Zydus US024, Omaha, Nebraska
Conditions: Primary Biliary Cholangitis